Glucose-6-phosphate dehydrogenase deficiency primary prevention: Difference between revisions
No edit summary |
No edit summary |
||
| Line 28: | Line 28: | ||
Effective measures for the primary prevention of G6PD defeceincy include:<ref name="pmid27040960">{{cite journal |vauthors=Luzzatto L, Nannelli C, Notaro R |title=Glucose-6-Phosphate Dehydrogenase Deficiency |journal=Hematol. Oncol. Clin. North Am. |volume=30 |issue=2 |pages=373–93 |date=April 2016 |pmid=27040960 |doi=10.1016/j.hoc.2015.11.006 |url=}}</ref> | Effective measures for the primary prevention of G6PD defeceincy include:<ref name="pmid27040960">{{cite journal |vauthors=Luzzatto L, Nannelli C, Notaro R |title=Glucose-6-Phosphate Dehydrogenase Deficiency |journal=Hematol. Oncol. Clin. North Am. |volume=30 |issue=2 |pages=373–93 |date=April 2016 |pmid=27040960 |doi=10.1016/j.hoc.2015.11.006 |url=}}</ref> | ||
*Avoiding triggers | *Avoiding triggers ( some foods and drugs) | ||
* | *<ref name="pmid18159462">{{cite journal |vauthors=Monga A, Makkar RP, Arora A, Mukhopadhyay S, Gupta AK |title=Case report: Acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency |journal=Can J Infect Dis |volume=14 |issue=4 |pages=230–1 |date=July 2003 |pmid=18159462 |pmc=2094938 |doi= |url=}}</ref> | ||
*[Measure3] | *[Measure3] | ||
Revision as of 19:15, 24 August 2018
|
Glucose-6-phosphate dehydrogenase deficiency Microchapters |
|
Differentiating Glucose-6-phosphate dehydrogenase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glucose-6-phosphate dehydrogenase deficiency primary prevention On the Web |
|
American Roentgen Ray Society Images of Glucose-6-phosphate dehydrogenase deficiency primary prevention |
|
FDA on Glucose-6-phosphate dehydrogenase deficiency primary prevention |
|
CDC on Glucose-6-phosphate dehydrogenase deficiency primary prevention |
|
Glucose-6-phosphate dehydrogenase deficiency primary prevention in the news |
|
Blogs on Glucose-6-phosphate dehydrogenase deficiency primary prevention |
|
Directions to Hospitals Treating Glucose-6-phosphate dehydrogenase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
There are no established measures for the primary prevention of [disease name].
OR
There are no available vaccines against [disease name].
OR
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
OR
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
Primary Prevention
There are no established measures for the primary prevention of [disease name].
OR
There are no available vaccines against [disease name].
OR
Effective measures for the primary prevention of G6PD defeceincy include:[1]
- Avoiding triggers ( some foods and drugs)
- [2]
- [Measure3]
OR
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]
References
- ↑ Luzzatto L, Nannelli C, Notaro R (April 2016). "Glucose-6-Phosphate Dehydrogenase Deficiency". Hematol. Oncol. Clin. North Am. 30 (2): 373–93. doi:10.1016/j.hoc.2015.11.006. PMID 27040960.
- ↑ Monga A, Makkar RP, Arora A, Mukhopadhyay S, Gupta AK (July 2003). "Case report: Acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency". Can J Infect Dis. 14 (4): 230–1. PMC 2094938. PMID 18159462.
|
Glucose-6-phosphate dehydrogenase deficiency Microchapters |
|
Differentiating Glucose-6-phosphate dehydrogenase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glucose-6-phosphate dehydrogenase deficiency primary prevention On the Web |
|
American Roentgen Ray Society Images of Glucose-6-phosphate dehydrogenase deficiency primary prevention |
|
FDA on Glucose-6-phosphate dehydrogenase deficiency primary prevention |
|
CDC on Glucose-6-phosphate dehydrogenase deficiency primary prevention |
|
Glucose-6-phosphate dehydrogenase deficiency primary prevention in the news |
|
Blogs on Glucose-6-phosphate dehydrogenase deficiency primary prevention |
|
Directions to Hospitals Treating Glucose-6-phosphate dehydrogenase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [4]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive hereditary disease featuring abnormally low levels of the G6PD enzyme, which plays an important role in red blood cell function. Individuals with the disease may exhibit non-immune hemolytic anemia in response to a number of causes. It is closely linked to favism, a disorder characterized by a hemolytic reaction to consumption of broad beans, with a name derived from the Italian name of the broad bean (fava). Sometimes the name, favism, is alternatively used to refer to the enzyme deficiency as a whole.
Primary Prevention
- The most important measure is prevention - avoidance of the drugs and foods that cause hemolysis.
- Vaccination against some common pathogens (e.g. hepatitis A) may prevent infection-induced attacks.